ADHD Treatments
FDA Approves Centanafadine, First-in-Class NDSRI Drug for ADHD in Adults and Children
5 sources · 9d ago
Alzheimer's Disease
FDA Approves First At-Home Starting Dose for Alzheimer's Drug Leqembi
3 sources · 15d ago
Gene Therapy
FDA Creates New 'Plausible Mechanism' Pathway to Approve Individualized Gene Therapies for Ultra-Rare Diseases
5 sources · 21d ago
More in Conditions & Diseases
Cancer InterceptionExplainer
Experimental KRAS Vaccine Shows Early Promise in Preventing Pancreatic Cancer
Preventative Oncologists 40%Immunology Researchers 35%Clinical Trial Methodologists 25%
7 sources · 28d ago
Prostate CancerTreatment Explainer
FDA Approves First Radioligand Therapy for Hormone-Sensitive Metastatic Prostate Cancer in Major Oncology Shift
Oncology Specialists 41%Patient Advocacy Groups 29%Industry & Market Analysts 29%
8 sources · 36d ago
Cholesterol CareMedical Breakthrough
FDA Approves First Oral PCSK9 Inhibitor to Lower Cholesterol, Offering Alternative to Injectables
Cardiologists & Lipid Specialists 40%Patient Advocacy Groups 30%Industry Analysts 30%
7 sources · 41d ago
ExplainerRespiratory Health
FDA Approves Ohtuvayre, the First COPD Drug with a Novel Mechanism in Over Two Decades
Clinical Researchers 40%Patient Advocates 30%Regulatory & Industry Analysts 30%
4 sources · 72d ago
ExplainerCeliac Pipeline
The Evidence Pack: How New Therapies Are Moving Celiac Disease Beyond the Gluten-Free Diet
Clinical Researchers 35%Patient Advocates 35%Factlen Editorial 30%
2 sources · 74d ago
ExplainerChronic Pain
The Evidence Pack: How Pain Reprocessing Therapy is Rewiring the Brain to Eliminate Chronic Pain
Neuroscience Researchers 40%Mind-Body Practitioners 35%Traditional Pain Specialists 25%
5 sources · 75d ago
EndometriosisMedical Breakthrough
The Evidence Pack: How Precision Peptides and Urine Tests Are Rewriting Endometriosis Care
Biotech Innovators 41%Diagnostic Researchers 35%Clinical Specialists 24%
4 sources · 75d ago
Cancer ScreeningExplainer
The Blood Test That Could Change Cancer Screening: What to Know About MCEDs
Test Developers & Advocates 45%Cautious Clinical Researchers 40%Regulatory & Policy Watchdogs 15%
6 sources · 77d ago
Organ TransplantationMedical Breakthrough
One Year Later: The World's First Bladder Transplant Patient is Thriving
Surgical Innovators 35%Clinical Researchers 35%Patient Advocates 30%
5 sources · 74d ago
Antibiotic ResistanceExplainer
FDA Approves Utebzi as First Oral Carbapenem Antibiotic for Complicated UTIs
Infectious Disease Specialists 35%Patients and Caregivers 35%Healthcare Economists 30%
6 sources · 56d ago
ExplainerCardiovascular Health
How COVID-19 Vaccination Protects the Heart: New Data Shows 38% Drop in Major Cardiac Events
Clinical Researchers 45%Public Health Officials 30%Practicing Cardiologists 25%
5 sources · 82d ago
Oncology InnovationExplainer
How mRNA Cancer Vaccines Work: The 5-Year Data Changing Oncology
Clinical Oncologists 45%Biopharma Manufacturers 35%Policy Skeptics 20%
3 sources · 92d ago















